Bristol-Myers Squibb Company

NYSE:BMY

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

💊 Pharmaceuticals

Location

United States

Market Cap

USD 93.53 B

Share Price

USD 45.95

Avg Daily Volume

15,593,212

Change (1 day)

1.30%

Change (1 year)

-1.92%

Change (YTD)

-18.76%

Bristol-Myers Squibb Company Operating Cash Flow for the Trailing 12 Months (TTM) ending June 30, 2025: USD 15.90 B

Bristol-Myers Squibb Company Operating Cash Flow is USD 15.90 B for the Trailing 12 Months (TTM) ending June 30, 2025, a 12.27% change year over year. Operating cash flow is cash generated from the company’s regular business operations.

Bristol-Myers Squibb Company Operating Cash Flow for the Trailing 12 Months (TTM) ending June 30, 2024 was USD 14.16 B, a 19.52% change year over year.
Bristol-Myers Squibb Company Operating Cash Flow for the Trailing 12 Months (TTM) ending June 30, 2023 was USD 11.85 B, a -23.03% change year over year.
Bristol-Myers Squibb Company Operating Cash Flow for the Trailing 12 Months (TTM) ending June 30, 2022 was USD 15.40 B, a 20.08% change year over year.
Bristol-Myers Squibb Company Operating Cash Flow for the Trailing 12 Months (TTM) ending June 30, 2021 was USD 12.82 B, a -1.56% change year over year.